Early-stage triple-negative breast cancer treated with locoregional therapy only - JAMA Oncology

Early-stage triple-negative breast cancer treated with locoregional therapy only – JAMA Oncology

JAMA Oncology shared on X/Twitter:

“In patients with early-stage triple-negative breast cancer treated with locoregional therapy only, higher levels of tumor-infiltrating lymphocytes in breast cancer tissue were associated with improved survival.”

Early-stage triple-negative breast cancer treated with locoregional therapy only - JAMA Oncology

Visit the article website.
Source: JAMA Oncology/X

Breast Cancer cancer early stage cancer JAMA Oncology locoregional therapy OncoDaily Oncology tumor infiltrating lymphocytes